SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Saroglitazar | 495399-09-2 | sc-473154 | 2.5 mg | $430.00 | ||
A dual PPARα/γ agonist, uniquely influencing lipid and glucose metabolism. By activating PPARα, it boosts lipid catabolism, effectively reducing triglycerides. Concurrently, its PPARγ activation enhances insulin sensitivity, aiding in glycemic regulation. This dual mechanism allows for a targeted modulation of metabolic pathways, making saroglitazar a compound of interest in metabolic research, particularly in understanding the interplay between lipid and glucose homeostasis. | ||||||
Teneligliptin | 760937-92-6 (free base) | sc-475074 | 25 mg | $260.00 | 1 | |
While primarily a DPP-4 inhibitor, teneligliptin has also shown some PPARy modulating effects, contributing to its anti-diabetic action. | ||||||